{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:13:34Z","timestamp":1779120814077,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2320,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/mt.2010.32","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T15:06:07Z","timestamp":1269356767000},"page":"1094-1102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Enhancement of Drug Delivery: Enzyme-replacement Therapy for Murine Morquio A Syndrome"],"prefix":"10.1016","volume":"18","author":[{"given":"Shunji","family":"Tomatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana M","family":"Monta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vu Chi","family":"Dung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amiko","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Oguma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Orii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S","family":"Sly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2010.32_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0076-6879(87)49041-1","article-title":"Lectin-specific targeting of lysosomal enzymes to reticuloendothelial cells","volume":"149","author":"Murray","year":"1987","journal-title":"Meth Enzymol"},{"key":"10.1038\/mt.2010.32_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0304-4165(81)90474-8","article-title":"Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation","volume":"673","author":"Furbish","year":"1981","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/mt.2010.32_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0092-8674(78)90102-2","article-title":"Human \u03b2-glucuronidase: in vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells","volume":"15","author":"Achord","year":"1978","journal-title":"Cell"},{"key":"10.1038\/mt.2010.32_bib4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1073\/pnas.75.3.1399","article-title":"Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages","volume":"75","author":"Stahl","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2010.32_bib5","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2010.32_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3928\/00904481-20090723-09","article-title":"Current enzyme replacement therapy for the treatment of lysosomal storage diseases","volume":"38","author":"Lim-Melia","year":"2009","journal-title":"Pediatr Ann"},{"key":"10.1038\/mt.2010.32_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2010.32_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet Med"},{"key":"10.1038\/mt.2010.32_bib9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/90242","article-title":"The HIV Tat protein transduction domain improves the biodistribution of \u03b2-glucuronidase expressed from recombinant viral vectors","volume":"19","author":"Xia","year":"2001","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2010.32_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-6147(03)00076-2","article-title":"Protein transduction domains: are they delivering?","volume":"24","author":"Green","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1038\/mt.2010.32_bib11","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1073\/pnas.0308728100","article-title":"Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice","volume":"101","author":"LeBowitz","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2010.32_bib12","doi-asserted-by":"crossref","first-page":"35037","DOI":"10.1074\/jbc.M402630200","article-title":"Lipoprotein receptor binding, cellular uptake, and lysosomal delivery of fusions between the receptor-associated protein (RAP) and \u03b1-l-iduronidase or acid \u03b1-glucosidase","volume":"279","author":"Prince","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.32_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ymthe.2005.02.031","article-title":"Defining the pathway for Tat-mediated delivery of \u03b2-glucuronidase in cultured cells and MPS VII mice","volume":"12","author":"Orii","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.32_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/03008208909002412","article-title":"The nature and significance of osteopontin","volume":"23","author":"Butler","year":"1989","journal-title":"Connect Tissue Res"},{"key":"10.1038\/mt.2010.32_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/10611869808995866","article-title":"Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. I.v. effects of osteotropic estradiol on bone mineral density and uterine weight in ovariectomized rats","volume":"5","author":"Fujisaki","year":"1998","journal-title":"J Drug Target"},{"key":"10.1038\/mt.2010.32_bib16","doi-asserted-by":"crossref","first-page":"19430","DOI":"10.1016\/S0021-9258(19)77651-0","article-title":"The primary structure of a cell-binding bone sialoprotein","volume":"263","author":"Oldberg","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.32_bib17","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1359\/jbmr.2000.15.5.936","article-title":"Selective drug delivery system to bone: small peptide (Asp)6 conjugation","volume":"15","author":"Kasugai","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"Pt 2","key":"10.1038\/mt.2010.32_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/bj2740513","article-title":"Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture","volume":"274","author":"Nagata","year":"1991","journal-title":"Biochem J"},{"key":"10.1038\/mt.2010.32_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/10611860108997922","article-title":"Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential","volume":"9","author":"Sekido","year":"2001","journal-title":"J Drug Target"},{"key":"10.1038\/mt.2010.32_bib20","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1210\/endo.142.3.8024","article-title":"Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice","volume":"142","author":"Yokogawa","year":"2001","journal-title":"Endocrinology"},{"key":"10.1038\/mt.2010.32_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymgme.2006.02.012","article-title":"Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide","volume":"88","author":"Nishioka","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2010.32_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1359\/jbmr.071213","article-title":"Enzyme replacement therapy for murine hypophosphatasia","volume":"23","author":"Mill\u00e1n","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1038\/mt.2010.32_bib23","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1073\/pnas.051623698","article-title":"Active site mutant transgene confers tolerance to human \u03b2-glucuronidase without affecting the phenotype of MPS VII mice","volume":"98","author":"Sly","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2010.32_bib24","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/ddg119","article-title":"Production of MPS VII mouse (Gus(tm(hE540A \u00d7 mE536A)Sly)) doubly tolerant to human and mouse \u03b2-glucuronidase","volume":"12","author":"Tomatsu","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2010.32_bib25","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1093\/hmg\/ddi364","article-title":"Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase","volume":"14","author":"Tomatsu","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2010.32_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0092-8674(03)00348-9","article-title":"The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases","volume":"113","author":"Cosma","year":"2003","journal-title":"Cell"},{"key":"10.1038\/mt.2010.32_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0092-8674(03)00347-7","article-title":"Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(\u03b1)-formylglycine generating enzyme","volume":"113","author":"Dierks","year":"2003","journal-title":"Cell"},{"key":"10.1038\/mt.2010.32_bib28","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/ddm353","article-title":"Enzyme replacement therapy in a murine model of Morquio A syndrome","volume":"17","author":"Tomatsu","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2010.32_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2007.01.004","article-title":"Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase","volume":"91","author":"Tomatsu","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2010.32_bib30","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1089\/hum.2005.16.929","article-title":"Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy","volume":"16","author":"Takakusaki","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.32_bib31","doi-asserted-by":"crossref","first-page":"12937","DOI":"10.1073\/pnas.91.26.12937","article-title":"Enzyme replacement in a canine model of Hurler syndrome","volume":"91","author":"Shull","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2010.32_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","article-title":"Fabry disease: preclinical studies demonstrate the effectiveness of \u03b1-galactosidase A replacement in enzyme-deficient mice","volume":"68","author":"Ioannou","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1038\/mt.2010.32_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1096\/fasebj.14.2.361","article-title":"Enzyme replacement therapy in a mouse model of aspartylglycosaminuria","volume":"14","author":"Dunder","year":"2000","journal-title":"FASEB J"},{"key":"10.1038\/mt.2010.32_bib34","doi-asserted-by":"crossref","first-page":"43160","DOI":"10.1074\/jbc.M107778200","article-title":"Biodistribution, kinetics, and efficacy of highly phosphorylated and non-phosphorylated \u03b2-glucuronidase in the murine model of mucopolysaccharidosis VII","volume":"276","author":"Sands","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.32_bib35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1006\/mgme.2000.3095","article-title":"Short-term enzyme replacement in the murine model of Sanfilippo syndrome type B","volume":"71","author":"Yu","year":"2000","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2010.32_bib36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ymgme.2008.01.007","article-title":"Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice","volume":"94","author":"Monta\u00f1o","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2010.32_bib37","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1073\/pnas.0712147105","article-title":"Chemically modified \u03b2-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII","volume":"105","author":"Grubb","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2010.32_bib38","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/hmg\/ddg366","article-title":"Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-\/-) produced by targeted disruption of the gene defective in Morquio A disease","volume":"12","author":"Tomatsu","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2010.32_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0009-8981(90)90339-T","article-title":"A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A)","volume":"187","author":"van Diggelen","year":"1990","journal-title":"Clin Chim Acta"},{"key":"10.1038\/mt.2010.32_bib40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0003-2697(79)90222-7","article-title":"Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall","volume":"100","author":"Peterson","year":"1979","journal-title":"Anal Biochem"},{"key":"10.1038\/mt.2010.32_bib41","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/bmc.760","article-title":"Analytical method for determination of disaccharides derived from keratan sulfates in human serum and plasma by high-performance liquid chromatography\/turbo-ionspray ionization tandem mass spectrometry","volume":"21","author":"Oguma","year":"2007","journal-title":"Biomed Chromatogr"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616310486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616310486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T11:21:04Z","timestamp":1725794464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616310486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1525001616310486"],"URL":"https:\/\/doi.org\/10.1038\/mt.2010.32","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of Drug Delivery: Enzyme-replacement Therapy for Murine Morquio A Syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2010.32","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}